This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08706/identifier/chemspider/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08706/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08706/identifier/drugbank/

Statements

Subject Item
n2:DB08706
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n9:DB08706 n10:DB08706
dcterms:title
(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID
adms:identifier
n7:VRX n11:13178234 n12:DB08706
n4:IUPAC-Name
n5:271B4BFA-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B4C00-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B4BFF-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B4BFC-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B4BFD-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B4BFE-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B4BF8-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B4BF9-363D-11E5-9242-09173F13E4C5 n5:271B4BF6-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B4BF7-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4C06-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4C07-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4C01-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4C02-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4C04-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4C03-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4C05-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4C0C-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B4C0E-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B4C0F-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B4C0B-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4C0A-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B4C0D-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B4BFB-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4C08-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4C09-363D-11E5-9242-09173F13E4C5